|1.||Mantovani, Alberto: 29 articles (02/2015 - 02/2003)|
|2.||Bottazzi, Barbara: 13 articles (10/2015 - 02/2003)|
|3.||Garlanda, Cecilia: 13 articles (02/2015 - 05/2006)|
|4.||Kodama, Tatsuhiko: 7 articles (06/2012 - 01/2007)|
|5.||Presta, Marco: 6 articles (08/2015 - 09/2005)|
|6.||Stenvinkel, Peter: 6 articles (05/2014 - 09/2007)|
|7.||Rovere-Querini, Patrizia: 6 articles (03/2012 - 07/2006)|
|8.||Manfredi, Angelo A: 5 articles (12/2014 - 07/2006)|
|9.||Peri, Giuseppe: 5 articles (02/2011 - 01/2005)|
|10.||Sagara, Mina: 5 articles (09/2010 - 01/2007)|
12/01/2015 - "It is known, that the long pentraxin, pentraxin 3 (PTX3) is produced at the sites of inflammation, therefore may better reflect activity of the local inflammatory processes. "
03/01/2015 - "Although pentraxin 3 (PTX3) is a vascular inflammation-related biomarker, little is known about PTX3 levels in patients with AAD. "
06/15/2014 - "microRNA-224 regulates Pentraxin 3, a component of the humoral arm of innate immunity, in inner ear inflammation."
06/01/2014 - "Pentraxin 3 (PTX3) is probably a specific marker of vascular inflammation. "
03/01/2014 - "Pentraxin 3 (PTX3) has been recently identified as a biomarker of vascular inflammation in predicting cardiovascular events. "
12/01/2015 - "Cardio-protective effects of pentraxin 3 produced from bone marrow-derived cells against ischemia/reperfusion injury."
04/01/2013 - "Since pentraxin 3 (PTX3) regulates multiple aspects of innate immunity and tissue inflammation, we tested whether PTX3 would be involved in renal ischemia-reperfusion injury. "
|3.||Cardiovascular Diseases (Cardiovascular Disease)
04/01/2009 - "Associations of pentraxin 3 with cardiovascular disease and all-cause death: the Cardiovascular Health Study."
01/01/2015 - "Pentraxin 3 (PTX3) was identified as a marker of the inflammatory response and overexpressed in various tissues and cells related to cardiovascular disease. "
09/01/2013 - "In theory, pentraxin 3 might modulate the inflammatory process involved in the pathogenesis of cardiovascular disease and represent a target for new therapies."
01/01/2013 - "Long pentraxin 3: experimental and clinical relevance in cardiovascular diseases."
12/01/2012 - "Cardiac rehabilitation decreases plasma pentraxin 3 in patients with cardiovascular diseases."
02/15/2011 - "This study investigated the clinical significance of plasma pentraxin 3 (PTX3) levels in patients with heart failure with normal ejection fraction (HFNEF) and whether PTX3 is produced from coronary circulation. "
10/30/2008 - "This study was designed to assess the clinical significance of plasma pentraxin 3 (PTX3) levels in chronic heart failure (CHF). "
08/01/2014 - "Incremental prognostic significance of the elevated levels of pentraxin 3 in patients with heart failure with normal left ventricular ejection fraction."
08/01/2013 - "The role of pentraxin 3 as diagnostic value in classification of patients with heart failure."
01/01/2013 - "Pentraxin 3 (PTX3) is rapidly produced in response to inflammatory signals, and high plasma PTX3 levels are seen in patients with heart failure. "
12/01/2015 - "Pentraxin 3 (PTX3), a soluble pattern recognition receptor, plays an important role in innate immunity and has been implicated to be a candidate resistance gene against Streptococcus suis 2 infection. "
07/01/2015 - "Pentraxin 3 (PTX3) is an acute phase reactant which has been used to detect intra-amniotic infections (IAI) in pregnancy, but the prognostic value of PTX3 concentrations on neonates has not been studied. "
01/01/2014 - "The long pentraxin, pentraxin 3 (PTX3), can play beneficial or detrimental roles during infection and disease by modulating various aspects of the immune system. "
08/01/2013 - "The long pentraxin 3 (PTX3) has been shown to be important in maintaining internal tissue homeostasis and in protecting against fungal Aspergillus fumigatus infection. "
01/01/2013 - "We studied plasma pentraxin 3 (PTX3) upon admission to the emergency department in patients with suspected infection. "
|1.||Hyaluronic Acid (Hyaluronan)
|3.||Interleukin-6 (Interleukin 6)
|4.||Interleukin-8 (Interleukin 8)
|5.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|6.||Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)
|8.||Carrier Proteins (Binding Protein)
|9.||Matrix Metalloproteinase 12
|10.||Troponin T (T, Troponin)
|1.||Renal Dialysis (Hemodialysis)
|2.||Drug Therapy (Chemotherapy)